Convincing results

Scientifically proven efficacy

The effectiveness and good tolerability of Pantogar^® capsules has been proven in comprehensive scientific studies.

A meta-analysis (evaluation of several studies) of Pantogar^® capsules, which comprises the results of 11 scientific studies involving a total of over 1,600 patients, proves the effectiveness of treatment with this combination of active ingredients for diffuse hair loss.

Studies involving Pantogar^®

At a dermatology conference in 2012, dermatologist Dr. med. Andreas Finner (Berlin) presented results of a study on the use of a combination of the active ingredients cystine, thiamine, calcium panthothenate and medicinal yeast in women with diffuse hair loss. This meta-analysis comprises the results of 11 scientific studies involving a total of over 1,600 patients and proves the effectiveness of treatment with this combination of active ingredients for diffuse hair loss.

The studies incorporated into this meta-analysis include the following

In a clinical and blinded* study of 30 otherwise healthy women, Lengg and colleagues investigated the effect of a product containing a combination of the active ingredients cystine, thiamine, calcium panthothenate and medicinal yeast for the treatment of diffuse hair loss. Taking the active ingredient medication for 6 months led to a normalisation of the number of hairs that were in the growth phase (anagen hair rate) and improved the overall impression of the hair status (1).

Another clinical and blinded* study by Budde and colleagues of 72 patients showed an increase in the number of hairs in the growth phase (anagen hair rate) in the group treated with a combination of cystine, thiamine, calcium panthothenate and medicinal yeast after just 4 months. Furthermore, the hair quality improved under this combination and at the same time the therapy was well tolerated (2).

In a multicentre observational study by Thomas Bergner, 1,194 patients with diffuse hair loss and 642 patients with nail growth disorders were studied. After 3-6 months of use, the therapeutic effect on hair loss and nail growth was assessed as good or very good by doctors and patients in 87-90% of the cases. The therapy reduced the number of hairs falling out daily to a normal level (80-100 hairs) (3).
Explanation of “blinded”: In this study, neither the doctor nor the patient knew which patients were administered the medication containing the active ingredient

¹Lengg, N., et al., Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind, placebo-controlled trial. Therapy, 2007. 4(1): p. 59-65.
²Budde, J., et al., [Systemic therapy of diffuse effluvium and hair structure damage]. Hautarzt, 1993. 44(6): p. 380-4.
³Bergner, T., Diffuses Effluvium, Haarstrukturschäden und Nagelwachstumsstörungen erfolgreich therapiert. Der deutsche Dermatologe, 1999. 47(11): p. 881-884.

Millions of satisfied women speak for themselves

For us, however, another confirmation of its efficacy is at least as important: Pantogar^® has already impressed and convinced millions of women worldwide.

An extensive survey has shown that the treatment results of ^® capsules significantly exceeded the expectations of women.*

70% of all affected women indicate that the success of the Pantogar^® treatment significantly exceeded their expectations. Some of these women have told us their personal experience so that other patients can also benefit from the right treatment without unnecessary detours.

* Opinion Market Research & Consulting GmbH, Germany, July 2008